@article{ref1,
title="SNI case of the week: Initial concomitant use of gabapentin, clonidine, and prednisone may enhance suicidal ideation: A case report",
journal="Surgical neurology international",
year="2020",
author="Ghaly, R.F. and Plesca, A. and Candido, K.D. and Knezevic, N.N.",
volume="11",
number="41",
pages="-",
abstract="BACKGROUND: Suicide cases are the end product of a combination of biological, clinical, psychological, social, and cultural risk/protective factors, and attempts to remain unpredictable. Case Description: A 43-year-old male presented to the hospital with jaundiced skin/eyes of 7 days' duration. He had a history of a major depressive disorder and chronic alcohol consumption (e.g., 3-5 alcoholic drinks/day for the past 15 years). Studies documented acute hepatic disease (e.g., biopsy-documented hepatocellular alcoholic hepatitis), accompanied by a cholestatic disease. The patient was discharged on clonidine, iron multivitamin, folic acid, gabapentin, and prednisone. Eight days postdischarge from the hospital, he committed suicide (e.g., self-inflicted gunshot wound to the head). <br><br>CONCLUSION: Concomitant administration of gabapentin, prednisone, and clonidine, especially if used for the first time, may play a synergistic effect in increasing a patient's suicide risk. © 2020 Scientific Scholar. All rights reserved.<p /><p>Language: en</p>",
language="en",
issn="2229-5097",
doi="10.25259/SNI_58_2020",
url="http://dx.doi.org/10.25259/SNI_58_2020"
}